ÂÜÀòÂÒÂ×

Maureen Clancy, MBA, PMP has extensive experience in leadership and program management in the biopharmaceutical industry. Maureen is currently the Vice President and Head of Global Program Leadership & Program Management, as well as the Global Product Leader at Kura Oncology, Inc. In this role, Maureen is responsible for leading and managing the Global Program Team and Global Product Team across the portfolio.

Prior to their current role, Maureen was the Head of Project, Program, and Portfolio Management, and Program Leader at Endo Pharmaceuticals. Maureen also held the position of Director of R&D Strategy and Portfolio at GSK, where they played a key role in the integration planning team for GSK/Novartis Oncology. Furthermore, they worked at AstraZeneca as the Director of R&D Strategy and Drug Project Management, leading projects in early and late development in the field of oncology.

In addition to their industry experience, Maureen is also a member of Chief, a private network focused on empowering senior women executives and promoting leadership diversity.

With their diverse background and expertise in the field, Maureen Clancy is a highly accomplished leader in the biopharmaceutical industry.

Maureen Clancy, MBA, PMP has a well-rounded education background. Maureen holds a Bachelor of Science (BS) degree in Chemistry from Seton Hall University. Additionally, they pursued further education and completed an Executive Education Program in Women's Executive Leadership: Business Strategies for Success from The Wharton School. Furthermore, Maureen attained a Master of Business Administration (MBA) degree through the Executive Program at the Fox School of Business at Temple University.

Maureen's commitment to professional development is evident in their additional certifications. Maureen obtained the Project Management Professional (PMP) certification from the Project Management Institute in July 2020. In June 2020, they achieved the Scrum Fundamentals Certified (SFC) designation from SCRUMstudy - Accreditation Body for Scrum and Agile. Moreover, they hold the Six Sigma Yellow Belt certification from 6SIGMAstudy - The global certification body for six sigma certifications, earned in June 2020. Maureen also completed courses such as Critical Thinking for Better Judgment and Decision-Making from LinkedIn and Tufts CSDD Leadership for Drug Development Teams from the Tufts Center for the Study of Drug Development, obtained in August 2022 and June 2023, respectively.